Identification of an androgen withdrawal responsive phenotype in castrate resistant prostate cancer (CRPC) patients (pts) treated with abiraterone acetate (AA)

被引：1
|
作者：
Logothetis, C. J.
Wen, S.
Molina, A.
Chieffo, N.
Smith, L. A.
Troncoso, P.
Efstathiou, E.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Cougar Biotechnol, Los Angeles, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.5017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5017
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Use of "intracrine androgen signaling signature" to predict benefit from abiraterone acetate (AA) in patients with castrate-resistant prostate cancer (CRPC)
    Efstathiou, E.
    Tu, S.
    Aparicio, A.
    Hoang, A.
    Wen, S.
    Troncoso, P.
    Smith, L. A.
    Chieffo, N.
    Molina, A.
    Logothetis, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] Androgen receptor (AR) mutations in patients (pts) with castration-resistant prostate cancer (CRPC) with and without prior abiraterone acetate (AA) treatment
    Rathkopf, Dana E.
    Smith, Matthew R.
    Antonarakis, Emmanuel S.
    Ryan, Charles J.
    Berry, William R.
    Shore, Neal D.
    Liu, Glenn
    Higano, Celestia
    Alumkal, Joshi J.
    Hauke, Ralph
    Tutrone, Ronald
    Saleh, Mansoor
    Maneval, Edna Chow
    Thomas, Shibu
    Ricci, Deborah
    Yu, Margaret K.
    de Boer, Carla J.
    Trinh, Angela
    Kheoh, Thian
    Bandekar, Rajesh
    Scher, Howard I.
    CANCER RESEARCH, 2015, 75
  • [3] Clinical benefit on abiraterone acetate (AA) in patients (pts) with PTEN loss castration-resistant prostate cancer (CRPC)
    Omlin, A.
    Pezaro, C.
    Reid, A.
    Rodrigues, D. Nava
    Riisnaes, R.
    Miranda, S.
    Tunariu, N.
    Lorente, D.
    Attard, G.
    De Bono, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S707 - S707
  • [4] Molecular characterization of circulating tumor cells (CTC) from castration-resistant prostate cancer (CRPC) patients (pts) treated with abiraterone acetate (AA)
    Attard, Gerhardt
    Swennenhuis, Joost
    Olmos, David
    Reid, Alison
    Coumans, Frank
    Vickers, Elaine
    Oommen, Nikhil Babu
    Thompson, Emilda
    A'Hern, Roger
    Cox, Michael
    Molina, Arturo
    Terstappen, Leon
    De Bono, Johann
    CANCER RESEARCH, 2009, 69
  • [5] Characterization of castrate resistant prostate cancer treated with abiraterone acetate and prednisone
    Efstathiou, Eleni
    Titus, Mark
    Tsavachidou, Dimitra
    Tzelepi, Vassiliki
    Wen, Sijin
    Anh Hoang
    Molina, Arturo
    Chieffo, Nicole
    Smith, Lisa A.
    Smith, B. S. R. N.
    Karlou, Maria Karlou
    Troncoso, Patricia
    Logothetis, Christopher J.
    CANCER RESEARCH, 2011, 71
  • [6] PSA response in black and white patients treated with abiraterone acetate (AA) for metastatic castrate resistant prostate cancer (mCRPC).
    Ramalingam, Sundhar
    Humeniuk, Michael Sandon
    Hu, Rachel
    Rasmussen, Julia
    Healy, Patrick
    Wu, Yuan
    Harrison, Michael Roger
    Armstrong, Andrew J.
    George, Daniel J.
    Zhang, Tian
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Examining experiences of patients currently being treated with abiraterone acetate (AA) for metastatic castrate resistant prostate cancer (mCRPC)
    Naim, Ahmad Bilal
    Roland, Barbara
    Wyant, Susan
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] A multicenter phase II study of abiraterone acetate (AA) in docetaxel pretreated castration-resistant prostate cancer (CRPC) patients (pts)
    Reid, A. H.
    Attard, G.
    Danila, D.
    Ryan, C. J.
    Thompson, E.
    Kheoh, T.
    Molina, A.
    Small, E.
    Scher, H.
    De-Bono, J. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [9] SAFETY OF ABIRATERONE ACETATE (AA) IN PATIENTS WITH CASTRATION RESISTANT PROSTATE CANCER (CRPC) AND CONCOMITANT CARDIAC RISK
    Procopio, G.
    Verzoni, E.
    Testa, I.
    Stagni, S.
    Villa, S.
    Valdagni, R.
    De Braud, F. G. M.
    ANNALS OF ONCOLOGY, 2012, 23 : 305 - 305
  • [10] Effects of Abiraterone Acetate on Androgen Signaling in Castrate-Resistant Prostate Cancer in Bone
    Efstathiou, Eleni
    Titus, Mark
    Tsavachidou, Dimitra
    Tzelepi, Vassiliki
    Wen, Sijin
    Anh Hoang
    Molina, Arturo
    Chieffo, Nicole
    Smith, Lisa A.
    Karlou, Maria
    Troncoso, Patricia
    Logothetis, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (06) : 637 - 643
12345